

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.35666039 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.30272307 |
| 3 | respiratory electron transport chain (GO:0022904) | 5.86349761 |
| 4 | protein complex biogenesis (GO:0070271) | 5.76765871 |
| 5 | electron transport chain (GO:0022900) | 5.76265186 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.75251870 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.75251870 |
| 8 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.24839437 |
| 9 | NADH dehydrogenase complex assembly (GO:0010257) | 5.24839437 |
| 10 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.24839437 |
| 11 | mitochondrial respiratory chain complex assembly (GO:0033108) | 5.23942852 |
| 12 | muscle filament sliding (GO:0030049) | 4.99856670 |
| 13 | actin-myosin filament sliding (GO:0033275) | 4.99856670 |
| 14 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.79875119 |
| 15 | respiratory chain complex IV assembly (GO:0008535) | 4.60642359 |
| 16 | cytochrome complex assembly (GO:0017004) | 4.47046284 |
| 17 | proteasome assembly (GO:0043248) | 4.42855887 |
| 18 | regulation of skeletal muscle contraction (GO:0014819) | 4.36488347 |
| 19 | chaperone-mediated protein transport (GO:0072321) | 4.32457683 |
| 20 | DNA deamination (GO:0045006) | 4.17168310 |
| 21 | actin-mediated cell contraction (GO:0070252) | 4.00692245 |
| 22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.92164520 |
| 23 | hydrogen ion transmembrane transport (GO:1902600) | 3.91316047 |
| 24 | cytidine deamination (GO:0009972) | 3.89096034 |
| 25 | cytidine metabolic process (GO:0046087) | 3.89096034 |
| 26 | cytidine catabolic process (GO:0006216) | 3.89096034 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 3.87284151 |
| 28 | protein neddylation (GO:0045116) | 3.71216059 |
| 29 | ATP biosynthetic process (GO:0006754) | 3.67913167 |
| 30 | ubiquinone biosynthetic process (GO:0006744) | 3.66454062 |
| 31 | proton transport (GO:0015992) | 3.64851444 |
| 32 | skeletal muscle contraction (GO:0003009) | 3.63546196 |
| 33 | hydrogen transport (GO:0006818) | 3.59284072 |
| 34 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.55681980 |
| 35 | response to muscle activity (GO:0014850) | 3.54641448 |
| 36 | regulation of relaxation of muscle (GO:1901077) | 3.52535141 |
| 37 | oxidative phosphorylation (GO:0006119) | 3.49050868 |
| 38 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.45385343 |
| 39 | protein targeting to mitochondrion (GO:0006626) | 3.44883782 |
| 40 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.43325806 |
| 41 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.32426700 |
| 42 | establishment of protein localization to mitochondrion (GO:0072655) | 3.26425089 |
| 43 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.25724068 |
| 44 | mitochondrial transport (GO:0006839) | 3.20779097 |
| 45 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.20089975 |
| 46 | inner mitochondrial membrane organization (GO:0007007) | 3.18108254 |
| 47 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.15028213 |
| 48 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.13159794 |
| 49 | AMP metabolic process (GO:0046033) | 3.13121693 |
| 50 | ubiquinone metabolic process (GO:0006743) | 3.13070408 |
| 51 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.12861683 |
| 52 | termination of RNA polymerase III transcription (GO:0006386) | 3.12861683 |
| 53 | protein localization to mitochondrion (GO:0070585) | 3.11667330 |
| 54 | intracellular protein transmembrane import (GO:0044743) | 3.11040820 |
| 55 | platelet dense granule organization (GO:0060155) | 3.10114994 |
| 56 | peptidyl-histidine modification (GO:0018202) | 3.09626580 |
| 57 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.07977454 |
| 58 | regulation of oxidative phosphorylation (GO:0002082) | 3.06403927 |
| 59 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.99287545 |
| 60 | regulation of hexokinase activity (GO:1903299) | 2.97628815 |
| 61 | regulation of glucokinase activity (GO:0033131) | 2.97628815 |
| 62 | quinone biosynthetic process (GO:1901663) | 2.96291970 |
| 63 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.95900110 |
| 64 | metallo-sulfur cluster assembly (GO:0031163) | 2.95357419 |
| 65 | iron-sulfur cluster assembly (GO:0016226) | 2.95357419 |
| 66 | regulation of cellular respiration (GO:0043457) | 2.95156543 |
| 67 | rRNA modification (GO:0000154) | 2.95133950 |
| 68 | purine nucleotide salvage (GO:0032261) | 2.94160521 |
| 69 | aerobic respiration (GO:0009060) | 2.93358180 |
| 70 | cellular response to zinc ion (GO:0071294) | 2.92580711 |
| 71 | cullin deneddylation (GO:0010388) | 2.88858890 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 2.85799301 |
| 73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.85484249 |
| 74 | mannosylation (GO:0097502) | 2.85089305 |
| 75 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.83355801 |
| 76 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.82096336 |
| 77 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.82096336 |
| 78 | protein deneddylation (GO:0000338) | 2.79593397 |
| 79 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.79094722 |
| 80 | pseudouridine synthesis (GO:0001522) | 2.79094326 |
| 81 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78248829 |
| 82 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.75072167 |
| 83 | NADH metabolic process (GO:0006734) | 2.71354653 |
| 84 | cellular respiration (GO:0045333) | 2.71248731 |
| 85 | negative regulation of ligase activity (GO:0051352) | 2.69641131 |
| 86 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.69641131 |
| 87 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.65913774 |
| 88 | GTP biosynthetic process (GO:0006183) | 2.65465832 |
| 89 | heart process (GO:0003015) | 2.65279418 |
| 90 | heart contraction (GO:0060047) | 2.65279418 |
| 91 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.64699776 |
| 92 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.64432935 |
| 93 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.64432935 |
| 94 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.63671309 |
| 95 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.63671309 |
| 96 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.63671309 |
| 97 | skeletal muscle fiber development (GO:0048741) | 2.62754643 |
| 98 | tricarboxylic acid cycle (GO:0006099) | 2.61719222 |
| 99 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.61397800 |
| 100 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.61190386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.28447881 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.86846896 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.78950268 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.15880963 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.97633768 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.88772580 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.83048462 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.76289224 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.31479223 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.28804895 |
| 11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 3.16996511 |
| 12 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.85044280 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.42549441 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.37404956 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.28674128 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.23054172 |
| 17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.05595411 |
| 18 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99483124 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92816533 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.88427514 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.88039558 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.84796852 |
| 23 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.81833349 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79126397 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78116648 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75372238 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.70542250 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69087199 |
| 29 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.66966827 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65567261 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.58221497 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.50492179 |
| 33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.48856004 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48292833 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44197522 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43108730 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42457515 |
| 38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42353498 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41490151 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39922066 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35545262 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.32871488 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30961305 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27986892 |
| 45 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27597923 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26642711 |
| 47 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22351361 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22285436 |
| 49 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.20428927 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15900092 |
| 51 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14396073 |
| 52 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11504928 |
| 53 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.11126430 |
| 54 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09637013 |
| 55 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07711193 |
| 56 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07711193 |
| 57 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07588469 |
| 58 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06935241 |
| 59 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06172358 |
| 60 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05301768 |
| 61 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.03584149 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02465025 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02013927 |
| 64 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99128565 |
| 65 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97330517 |
| 66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97330517 |
| 67 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96635293 |
| 68 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94951680 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94765202 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94520955 |
| 71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93196395 |
| 72 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92195661 |
| 73 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91716142 |
| 74 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.88061757 |
| 75 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86659261 |
| 76 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86244182 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85466563 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85065928 |
| 79 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.84909846 |
| 80 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.84386418 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83956252 |
| 82 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.83930559 |
| 83 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.83850741 |
| 84 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82509612 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82391161 |
| 86 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.81959858 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80706860 |
| 88 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.80348920 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79427309 |
| 90 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.79228133 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78292318 |
| 92 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76627044 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.76112881 |
| 94 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.75297789 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75200670 |
| 96 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.74050882 |
| 97 | ERA_21632823_ChIP-Seq_H3396_Human | 0.73943709 |
| 98 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73412642 |
| 99 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.73314971 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72730597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.88595953 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.45307013 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 4.19511489 |
| 4 | MP0000749_muscle_degeneration | 4.04313141 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.88596444 |
| 6 | MP0006036_abnormal_mitochondrial_physio | 3.50463904 |
| 7 | MP0000372_irregular_coat_pigmentation | 2.74658946 |
| 8 | MP0000751_myopathy | 2.62756123 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.53986349 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.31366719 |
| 11 | MP0005330_cardiomyopathy | 2.07806528 |
| 12 | MP0003186_abnormal_redox_activity | 2.05278327 |
| 13 | MP0002106_abnormal_muscle_physiology | 1.98967490 |
| 14 | MP0003011_delayed_dark_adaptation | 1.97606304 |
| 15 | MP0002163_abnormal_gland_morphology | 1.88398295 |
| 16 | MP0002332_abnormal_exercise_endurance | 1.87908288 |
| 17 | MP0002876_abnormal_thyroid_physiology | 1.85434536 |
| 18 | MP0005620_abnormal_muscle_contractility | 1.81147997 |
| 19 | MP0004215_abnormal_myocardial_fiber | 1.79414516 |
| 20 | MP0000750_abnormal_muscle_regeneration | 1.74491847 |
| 21 | MP0003195_calcinosis | 1.69529890 |
| 22 | MP0002269_muscular_atrophy | 1.69461444 |
| 23 | MP0005369_muscle_phenotype | 1.68149506 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.65328294 |
| 25 | MP0001905_abnormal_dopamine_level | 1.64373132 |
| 26 | MP0000759_abnormal_skeletal_muscle | 1.61982131 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 1.59694450 |
| 28 | MP0004142_abnormal_muscle_tone | 1.58993654 |
| 29 | MP0004147_increased_porphyrin_level | 1.56419967 |
| 30 | MP0005266_abnormal_metabolism | 1.54307636 |
| 31 | MP0005332_abnormal_amino_acid | 1.46641005 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.43774223 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.43068469 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.42415866 |
| 35 | MP0004087_abnormal_muscle_fiber | 1.40973996 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.40820336 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.38100223 |
| 38 | MP0000747_muscle_weakness | 1.37908238 |
| 39 | MP0003786_premature_aging | 1.36978935 |
| 40 | MP0001764_abnormal_homeostasis | 1.34951948 |
| 41 | MP0005451_abnormal_body_composition | 1.29363474 |
| 42 | MP0009046_muscle_twitch | 1.28237563 |
| 43 | MP0003137_abnormal_impulse_conducting | 1.27636380 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.24479504 |
| 45 | MP0001984_abnormal_olfaction | 1.23962543 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.23788802 |
| 47 | MP0001529_abnormal_vocalization | 1.22076969 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.19907454 |
| 49 | MP0002693_abnormal_pancreas_physiology | 1.19362624 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.19204531 |
| 51 | MP0001661_extended_life_span | 1.15001642 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.12328111 |
| 53 | MP0005253_abnormal_eye_physiology | 1.12217152 |
| 54 | MP0005410_abnormal_fertilization | 1.08596281 |
| 55 | MP0008872_abnormal_physiological_respon | 1.02606556 |
| 56 | MP0001873_stomach_inflammation | 1.01141101 |
| 57 | MP0002822_catalepsy | 1.00953598 |
| 58 | MP0003950_abnormal_plasma_membrane | 0.99150549 |
| 59 | MP0009697_abnormal_copulation | 0.97768263 |
| 60 | MP0004484_altered_response_of | 0.96638435 |
| 61 | MP0005646_abnormal_pituitary_gland | 0.96393786 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.95228629 |
| 63 | MP0008775_abnormal_heart_ventricle | 0.94924112 |
| 64 | MP0000343_altered_response_to | 0.94106722 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 0.93796931 |
| 66 | MP0001544_abnormal_cardiovascular_syste | 0.92300048 |
| 67 | MP0005385_cardiovascular_system_phenoty | 0.92300048 |
| 68 | MP0002160_abnormal_reproductive_system | 0.90663251 |
| 69 | MP0004043_abnormal_pH_regulation | 0.90633213 |
| 70 | MP0004130_abnormal_muscle_cell | 0.89477124 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 0.89028167 |
| 72 | MP0002127_abnormal_cardiovascular_syste | 0.88725470 |
| 73 | MP0009745_abnormal_behavioral_response | 0.86350697 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.85887927 |
| 75 | MP0004510_myositis | 0.81111916 |
| 76 | MP0002272_abnormal_nervous_system | 0.80955854 |
| 77 | MP0005670_abnormal_white_adipose | 0.80776917 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79962814 |
| 79 | MP0006276_abnormal_autonomic_nervous | 0.78463567 |
| 80 | MP0005535_abnormal_body_temperature | 0.77383846 |
| 81 | MP0002132_abnormal_respiratory_system | 0.77288769 |
| 82 | MP0005389_reproductive_system_phenotype | 0.77226353 |
| 83 | MP0004233_abnormal_muscle_weight | 0.76767544 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 0.76593856 |
| 85 | MP0002938_white_spotting | 0.76497935 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.76368117 |
| 87 | MP0002108_abnormal_muscle_morphology | 0.75939874 |
| 88 | MP0004085_abnormal_heartbeat | 0.75387409 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.75209572 |
| 90 | MP0008058_abnormal_DNA_repair | 0.73925857 |
| 91 | MP0003880_abnormal_central_pattern | 0.73736400 |
| 92 | MP0008995_early_reproductive_senescence | 0.73065568 |
| 93 | MP0005365_abnormal_bile_salt | 0.72699301 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.72093392 |
| 95 | MP0001756_abnormal_urination | 0.70588290 |
| 96 | MP0001968_abnormal_touch/_nociception | 0.70464027 |
| 97 | MP0002102_abnormal_ear_morphology | 0.70216535 |
| 98 | MP0001944_abnormal_pancreas_morphology | 0.69872997 |
| 99 | MP0001542_abnormal_bone_strength | 0.68108052 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.67757031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.99262722 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.79730132 |
| 3 | Nemaline bodies (HP:0003798) | 5.77962640 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 5.65343511 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.25852303 |
| 6 | Mitochondrial inheritance (HP:0001427) | 5.20292208 |
| 7 | Progressive macrocephaly (HP:0004481) | 4.86325862 |
| 8 | Acute encephalopathy (HP:0006846) | 4.79590015 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.65313385 |
| 10 | Increased CSF lactate (HP:0002490) | 4.53865663 |
| 11 | Hepatic necrosis (HP:0002605) | 4.47624111 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 4.33190530 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.96446157 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.95950139 |
| 15 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.89163320 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.89163320 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 3.84899838 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 3.82339231 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.71774761 |
| 20 | Increased muscle lipid content (HP:0009058) | 3.62978398 |
| 21 | Cerebral edema (HP:0002181) | 3.62793480 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.59311460 |
| 23 | Exercise intolerance (HP:0003546) | 3.58389462 |
| 24 | Type 1 muscle fiber predominance (HP:0003803) | 3.48359553 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.45343790 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 3.41757896 |
| 27 | Myoglobinuria (HP:0002913) | 3.40619838 |
| 28 | Distal arthrogryposis (HP:0005684) | 3.36969074 |
| 29 | Lactic acidosis (HP:0003128) | 3.29242710 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 3.28313900 |
| 31 | Respiratory failure (HP:0002878) | 3.26438962 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.14278604 |
| 33 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.05132471 |
| 34 | Myopathic facies (HP:0002058) | 2.97682683 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.96071997 |
| 36 | Increased serum lactate (HP:0002151) | 2.88182738 |
| 37 | Rimmed vacuoles (HP:0003805) | 2.86033564 |
| 38 | Abnormality of the calf musculature (HP:0001430) | 2.77813147 |
| 39 | Exertional dyspnea (HP:0002875) | 2.50145801 |
| 40 | Optic disc pallor (HP:0000543) | 2.49453188 |
| 41 | Neck muscle weakness (HP:0000467) | 2.49383487 |
| 42 | Ketoacidosis (HP:0001993) | 2.46383688 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.44669678 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44669678 |
| 45 | Hyporeflexia of lower limbs (HP:0002600) | 2.40751492 |
| 46 | Lethargy (HP:0001254) | 2.39836810 |
| 47 | Muscle fiber splitting (HP:0003555) | 2.30666733 |
| 48 | CNS demyelination (HP:0007305) | 2.26358096 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.26149985 |
| 50 | Round ear (HP:0100830) | 2.24947416 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.19957315 |
| 52 | Ketosis (HP:0001946) | 2.19849531 |
| 53 | Methylmalonic acidemia (HP:0002912) | 2.17476516 |
| 54 | Leukodystrophy (HP:0002415) | 2.17376609 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.15659162 |
| 56 | Glycosuria (HP:0003076) | 2.15659162 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.14922200 |
| 58 | Muscle stiffness (HP:0003552) | 2.14467389 |
| 59 | Methylmalonic aciduria (HP:0012120) | 2.12964572 |
| 60 | Type 2 muscle fiber atrophy (HP:0003554) | 2.09665039 |
| 61 | Palpitations (HP:0001962) | 2.09127365 |
| 62 | Emotional lability (HP:0000712) | 2.06194749 |
| 63 | Hypothermia (HP:0002045) | 2.02101971 |
| 64 | Abnormality of renal resorption (HP:0011038) | 1.98847664 |
| 65 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97027873 |
| 66 | Muscle fiber atrophy (HP:0100295) | 1.95830900 |
| 67 | Ulnar deviation of the wrist (HP:0003049) | 1.94947017 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94667687 |
| 69 | Absent phalangeal crease (HP:0006109) | 1.93548490 |
| 70 | Myotonia (HP:0002486) | 1.91602997 |
| 71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90734312 |
| 72 | Increased serum pyruvate (HP:0003542) | 1.88973641 |
| 73 | Hypoglycemic coma (HP:0001325) | 1.88183426 |
| 74 | X-linked dominant inheritance (HP:0001423) | 1.86937624 |
| 75 | Large for gestational age (HP:0001520) | 1.85968803 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.85715174 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.85715174 |
| 78 | Abnormal protein glycosylation (HP:0012346) | 1.85715174 |
| 79 | Abnormal glycosylation (HP:0012345) | 1.85715174 |
| 80 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84676888 |
| 81 | Reduced antithrombin III activity (HP:0001976) | 1.84625015 |
| 82 | Malignant hyperthermia (HP:0002047) | 1.82048443 |
| 83 | Respiratory difficulties (HP:0002880) | 1.81988071 |
| 84 | Areflexia of lower limbs (HP:0002522) | 1.81698288 |
| 85 | Abnormal pupillary function (HP:0007686) | 1.80266217 |
| 86 | Sudden death (HP:0001699) | 1.79110051 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78960192 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 1.78960192 |
| 89 | Hyperalaninemia (HP:0003348) | 1.78960192 |
| 90 | Ragged-red muscle fibers (HP:0003200) | 1.77940291 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.76435766 |
| 92 | Aplastic anemia (HP:0001915) | 1.75205911 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 1.75033924 |
| 94 | Paralysis (HP:0003470) | 1.74819164 |
| 95 | Abnormality of placental membranes (HP:0011409) | 1.74538665 |
| 96 | Amniotic constriction ring (HP:0009775) | 1.74538665 |
| 97 | Frequent falls (HP:0002359) | 1.71122854 |
| 98 | Abnormal number of erythroid precursors (HP:0012131) | 1.69604837 |
| 99 | Abnormality of glycolysis (HP:0004366) | 1.69104769 |
| 100 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.66163903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.82065069 |
| 2 | PHKG1 | 3.96229590 |
| 3 | PHKG2 | 3.96229590 |
| 4 | VRK2 | 3.84108172 |
| 5 | PINK1 | 3.55715933 |
| 6 | NME2 | 2.32823887 |
| 7 | MAP4K2 | 2.32662264 |
| 8 | BCKDK | 2.27908017 |
| 9 | MST4 | 2.26253797 |
| 10 | MAPKAPK3 | 2.24076584 |
| 11 | FRK | 2.20834101 |
| 12 | TXK | 2.18530639 |
| 13 | NME1 | 2.18389096 |
| 14 | LIMK1 | 2.16225599 |
| 15 | MAP3K12 | 1.69899854 |
| 16 | VRK1 | 1.69337447 |
| 17 | ZAK | 1.62710641 |
| 18 | TTN | 1.61779467 |
| 19 | BMPR1B | 1.56535740 |
| 20 | ADRBK2 | 1.54907654 |
| 21 | GRK1 | 1.47374907 |
| 22 | MUSK | 1.44407189 |
| 23 | MYLK | 1.43585737 |
| 24 | NUAK1 | 1.39319816 |
| 25 | BUB1 | 1.38066937 |
| 26 | NEK1 | 1.36504793 |
| 27 | STK16 | 1.36415697 |
| 28 | INSRR | 1.35192657 |
| 29 | PDK2 | 1.32749831 |
| 30 | PIM2 | 1.25045145 |
| 31 | TESK1 | 1.17401172 |
| 32 | TLK1 | 1.14468729 |
| 33 | KDR | 1.09804818 |
| 34 | TIE1 | 1.06369588 |
| 35 | PIK3CG | 1.04438549 |
| 36 | ABL2 | 0.99160204 |
| 37 | ARAF | 0.98642435 |
| 38 | MAP2K6 | 0.93079399 |
| 39 | PBK | 0.91629134 |
| 40 | CCNB1 | 0.91436572 |
| 41 | CSNK1G3 | 0.91435783 |
| 42 | CSNK1G1 | 0.90671431 |
| 43 | DAPK1 | 0.90272372 |
| 44 | EIF2AK3 | 0.88081532 |
| 45 | MAP2K7 | 0.87688566 |
| 46 | WNK3 | 0.86473672 |
| 47 | ILK | 0.85296353 |
| 48 | DAPK3 | 0.81289906 |
| 49 | MAP3K11 | 0.78579428 |
| 50 | EIF2AK1 | 0.77739935 |
| 51 | CAMK2D | 0.77728302 |
| 52 | TESK2 | 0.77550421 |
| 53 | CAMK2G | 0.77012743 |
| 54 | GRK5 | 0.76110656 |
| 55 | MAPK13 | 0.71443976 |
| 56 | CSNK1G2 | 0.70057843 |
| 57 | ERBB3 | 0.69735430 |
| 58 | MAPK12 | 0.67400653 |
| 59 | GRK7 | 0.64398045 |
| 60 | RPS6KA5 | 0.64044810 |
| 61 | DYRK2 | 0.61313329 |
| 62 | SRPK1 | 0.59590757 |
| 63 | IKBKB | 0.56699984 |
| 64 | MARK3 | 0.55359540 |
| 65 | DAPK2 | 0.54896262 |
| 66 | CAMK2A | 0.53845712 |
| 67 | PRKACA | 0.53340599 |
| 68 | TRIM28 | 0.49722038 |
| 69 | CSNK1A1L | 0.49268702 |
| 70 | PRKG1 | 0.47659346 |
| 71 | TNK2 | 0.45495744 |
| 72 | PAK1 | 0.45077458 |
| 73 | PAK3 | 0.44321798 |
| 74 | PRKCE | 0.43658352 |
| 75 | AURKA | 0.43617994 |
| 76 | ADRBK1 | 0.43243926 |
| 77 | AKT2 | 0.42937749 |
| 78 | PRKCQ | 0.42708609 |
| 79 | CSNK1A1 | 0.42051039 |
| 80 | CAMK1 | 0.41335192 |
| 81 | PRKCI | 0.38501026 |
| 82 | TAOK3 | 0.37794639 |
| 83 | CSNK2A2 | 0.37693273 |
| 84 | PKN1 | 0.35873344 |
| 85 | ROCK1 | 0.35791592 |
| 86 | PRKG2 | 0.34471269 |
| 87 | CSNK2A1 | 0.34461712 |
| 88 | BRAF | 0.32984217 |
| 89 | PRKCA | 0.32756695 |
| 90 | PLK3 | 0.30505054 |
| 91 | PRKAA1 | 0.29678658 |
| 92 | PRKACB | 0.28255091 |
| 93 | PRKCG | 0.27797560 |
| 94 | PLK1 | 0.25647292 |
| 95 | TBK1 | 0.25363632 |
| 96 | TEC | 0.24782080 |
| 97 | PLK2 | 0.23644289 |
| 98 | MOS | 0.23101938 |
| 99 | PTK2B | 0.22540672 |
| 100 | CAMKK2 | 0.21846302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.18247404 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.39920397 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.71976696 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.09384521 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.96882280 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.89469642 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.79963346 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.77406696 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.42516297 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.33874908 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02718006 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.76730675 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.73896170 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.73302842 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68051741 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58342057 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56046547 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54767392 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54010203 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53415332 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52658925 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.44610494 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43526778 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42633244 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.41519921 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.33360143 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32702225 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29631923 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24679395 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24626875 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.14768833 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.08769159 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08035423 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.02380777 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99064554 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 0.97405377 |
| 37 | Metabolic pathways_Homo sapiens_hsa01100 | 0.97052670 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.94415229 |
| 39 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92084976 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90718274 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88898346 |
| 42 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87559356 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87216468 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86784990 |
| 45 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85395253 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85226136 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.84184726 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 0.79888904 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.79422919 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79086864 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78344247 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77383657 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77167420 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75460728 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72825849 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72251067 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70007925 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68926386 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68570390 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68378463 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68350668 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65486673 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65376666 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.65030290 |
| 65 | Mismatch repair_Homo sapiens_hsa03430 | 0.64898630 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63128869 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63006577 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57398162 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56031953 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.55127688 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53245222 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51522778 |
| 73 | DNA replication_Homo sapiens_hsa03030 | 0.49434120 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48499045 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47370418 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46184780 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42695097 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42417779 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41985880 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.40814518 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40205529 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40044296 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39426979 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38401114 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37802340 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37663288 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36912132 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36354582 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34648192 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33529041 |
| 91 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.32950820 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31090437 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30148896 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29974102 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.29149040 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28589142 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28143523 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27275053 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26725318 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26313253 |

